Dominique Lejeune
0000-0002-0981-0486
5 papers found
Refreshing results…
Comparative Effectiveness and Safety of Rivaroxaban and Warfarin Among Nonvalvular Atrial Fibrillation (NVAF) Patients with Obesity and Polypharmacy in the United States (US)
Real-world effectiveness and safety of rivaroxaban versus warfarin among non-valvular atrial fibrillation patients with obesity in a US population
Healthcare resource utilization and costs of rivaroxaban versus warfarin among non-valvular atrial fibrillation (NVAF) patients with obesity in a US population
The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation
Clinical outcomes of prolonged anticoagulation with rivaroxaban after unprovoked venous thromboembolism
Missing publications? Search for publications with a matching author name.